Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 394 Triple Negative Breast Neoplasms 69 Ovarian Neoplasms 49 Prostatic Neoplasms 36 Colorectal Neoplasms 36 Carcinoma, Non-Small-Cell Lung 30 Neoplasms 27 Endometrial Neoplasms 24 Neoplasm Metastasis 23 Lung Neoplasms 21 Stomach Neoplasms 19 Melanoma 19 Squamous Cell Carcinoma of Head and Neck 18 Pancreatic Neoplasms 18 Uterine Cervical Neoplasms 17 Carcinoma, Renal Cell 16 Urinary Bladder Neoplasms 13 Head and Neck Neoplasms 12 Esophageal Neoplasms 12 Small Cell Lung Carcinoma 10 Sarcoma 10 Kidney Neoplasms 9 Colonic Neoplasms 9 Advanced Breast Cancer 8 Liver Neoplasms 7 Carcinoma, Transitional Cell 7 HER2-positive Breast Cancer 6 Gastrointestinal Neoplasms 6 Depression 6 Cholangiocarcinoma 6

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × Breast × 30 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡